Werum and Sarla boost paperless pharma manufacturing in India

Anil Mehta, CEO, Sarla TechnologiesSarla Technologies and Werum IT Solutions, the world’s leading supplier of manufacturing execution systems (MES) and manufacturing IT solutions for the pharmaceutical and biopharmaceutical industries, jointly announced an MOU to partner for delivering MES projects in India. Sarla Technologies will become an official partner for Werum’s PAS-X MES throughout India providing project control and integration services.

Integration and automation know-how Werum’s PAS-X MES enables pharmaceutical facilities to run manufacturing processes completely paperless at the highest level and to be compliant with international GMP guidelines and FDA regulations. The requirements of the pharmaceutical industry are directly addressed by Werum’s out-of-the-box solution without any need for expensive and time-consuming customisation. Based on standard functionality and best practice content, pharmaceutical manufacturers will be able to have the number one global MES solution up and running in a very short time. 

Lars Hornung

‘We’re very pleased that Sarla Technologies will join us as a partner to expand our presence in India and to leverage its great experience and track record in the Indian pharmaceutical industry and also in automation and process control for projects requiring complete integration with machines and equipment,’ says Lars Hornung, senior director global sales, Werum IT Solutions. ‘Together with Sarla Technologies we will be able to offer our best-in-class PAS-X MES package together with an optimised deployment model to our customers in India.’

Anil Mehta, CEO, Sarla Technologies, adds: ‘Our partnership with Werum enables multinationals and leading pharmaceutical companies in India to gain full advantage of MES. PAS-X and Werum’s expertise along with Sarla’s Level 2 integration and automation know-how will help them tremendously to increase productivity and meet global regulatory requirements.’


Subscribe to our mailing list

* indicates required

Would you like to receive our FREE e-newsletter?

* indicates required
Close